S1631 Restoring Safeguards for Dangerous Abortion Drugs Act

↓Restricts abortion access model confidence 95%

Requires a stricter REMS for mifepristone identical to the 2011 version (with in-person dispensing and other limits) and bans its importation, so less access to medication abortion.

(2) approve a risk evaluation and mitigation strategy for the covered medication that is identical to the risk evaluation and mitigation strategy for such covered medication that was approved by such Secretary in June 2011.

✓ Quote verified word for word in the bill text

↓Restricts abortion access model confidence 90%

Imposes a federal REMS requirement on mifepristone that cannot be loosened and adds a ban on its importation, so tighter regulation of medication-abortion providers and distribution.

the Secretary of Health and Human Services shall-- (1) withdraw approval of the risk evaluation and mitigation strategy ... that is in effect on the date of enactment of this Act; and (2) approve a risk evaluation and mitigation strategy for the covered medication that is identical to the risk evaluation and mitigation strategy for such covered medication that was approved by such Secretary in June 2011.

⚠ Quote could not be matched to the bill text: treat this label with caution

↓Restricts abortion access model confidence 85%

Creates a federal tort cause of action allowing civil suits for harms from mifepristone (including by telehealth providers and pharmacies), increasing liability for entities involved in medication abortion.

A covered entity shall be liable in accordance with this section to any individual who suffers bodily injury or harm to mental health ... that is attributable, in whole or in part, to the individual's use of a covered medication imported or transported as described in subsection (a).

⚠ Quote could not be matched to the bill text: treat this label with caution